The RENAISSANCE (AIO-FLOT5) trial: effect of chemotherapy alone vs. chemotherapy followed by surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction –
Treatment Switch in Poor Responders with Locally Advanced Gastric Cancer After Neoadjuvant Chemotherapy | SpringerLink
FLOT and CROSS chemotherapy regimens alter the frequency of CD27+ and CD69+ T cells in oesophagogastric adenocarcinomas: implications for combination with immunotherapy | SpringerLink
FLOT and CROSS chemotherapy regimens significantly upregulate DAMPs on... | Download Scientific Diagram
Frontiers | VESTIGE: Adjuvant Immunotherapy in Patients With Resected Esophageal, Gastroesophageal Junction and Gastric Cancer Following Preoperative Chemotherapy With High Risk for Recurrence (N+ and/or R1): An Open Label Randomized Controlled Phase-2 ...
ASCO 2017: Perioperative chemotherapy with docetaxel, oxaliplatin, and fluorouracil/leucovorin (FLOT) versus epirubicin, cisplatin, and fluorouracil or capecitabine (ECF/ECX) for resectable gastric or gastroesophageal junction (GEJ) adenocarcinoma ...
FLOT and CROSS chemotherapy regimens significantly upregulate DAMPs on... | Download Scientific Diagram
RACE-trial: neoadjuvant radiochemotherapy versus chemotherapy for patients with locally advanced, potentially resectable adenocarcinoma of the gastroesophageal junction - a randomized phase III joint study of the AIO, ARO and DGAV | BMC
Chemotherapy regimens induce inhibitory immune checkpoint protein expression on stem-like and senescent-like oesophageal adenocarcinoma cells - ScienceDirect
Vaibhav Gupta, MD, PhD on Twitter: "FLOT = new standard of care chemotherapy for GEJ and gastric cancer? Publication pending @ISDE_net @GastricCancerFD @mygutfeelingca @SalgiFoundation @CAGS_ACCG @ThoracicsCanada @DrNCoburn https://t.co/A7MkWH3lhG ...
KEYNOTE-585: Phase III study of perioperative chemotherapy with or without pembrolizumab for gastric cancer | Future Oncology
Overall survival for FLOT-first versus surgery-first in patients with... | Download Scientific Diagram
Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a ...
Exploring FLOT- and FOLFOX-Based total neoadjuvant therapy for patients with locally advanced gastroesophageal cancers
Feasibility of perioperative chemotherapy with infusional 5-FU, leucovorin, and oxaliplatin with (FLOT) or without (FLO) docetaxel in elderly patients with locally advanced esophagogastric cancer | British Journal of Cancer
PDF) Perioperative FLOT chemotherapy plus surgery for oligometastatic esophagogastric adenocarcinoma: surgical outcome and overall survival
Efficacy and Safety of FLOT regimen vs. DCF, FOLFOX, and ECF regimens as Perioperative Chemotherapy Treatments for Resectable Gastric Cancer Patients | medRxiv
What is the regimen for FLOT chemotherapy?
Perioperative chemotherapy with 5-FU, leucovorin, oxaliplatin, and docetaxel (FLOT) for esophagogastric adenocarcinoma: ten years real-life experience from a surgical perspective | SpringerLink
NEO- AND ADJUVANT TREATMENT FOR GASTRIC CANCER: THE ROLE OF CHEMOTHERAPY
Therapieoptionen beim oligometastasierten Magenkarzinom | SpringerLink
